×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| TRANSGENE BIOTEK LTD. | 1.21 | -0.88 | 0.77 | -0.01 | 32.0 | |
| VEERHEALTH CARE LIMITED | 40.18 | 0.71 | 38.39 | 0.04 | 30 | |
| SAMSRITA LABS LIMITED | NA | -0.41 | NA | -0.03 | 29.5 |
Transgene Biotek Ltd., with Security Code 526139, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.0 | 0.0 | 0.0 | 9.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Expenses | 2.6 | 2.6 | 0.2 | 0.1 | 22.0 | 0.2 | 0.2 | 0.3 | 0.5 | 0.1 |
| Operating Profit | 2.6 | -2.6 | 0.2 | -0.1 | -12.0 | -0.1 | -0.1 | -0.3 | -0.4 | -0.1 |
| OPM % | 2599% | -129450% | 159% | -65.88% | -120.15% | -268.89% | -240% | -595.56% | -842.86% | -130.51% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.1 | 4.4 | 0.0 | 0.0 | 0.1 | 0.7 | 0.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 3.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 2.5 | 2.5 | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Profit before tax | 2.6 | -2.6 | -2.3 | -2.5 | -13.2 | -0.1 | -0.1 | -0.3 | 0.2 | -0.1 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -2.6 | -2.6 | -2.6 | -2.5 | -13.2 | -0.1 | -0.1 | -0.3 | 0.2 | -0.1 |
| EPS in Rs | -0.34 | -0.34 | -0.35 | -0.34 | -0.02 | -0.02 | -0.02 | -0.04 | 0.03 | -0.01 |
| Metrics | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.0 | 0.1 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| Expenses | 2.6 | 0.2 | 0.1 | 22.7 | 0.2 | 0.2 | 0.3 | 0.5 | 0.1 | 0.2 |
| Operating Profit | -2.6 | -0.2 | -0.1 | -12.7 | -0.1 | -0.1 | -0.3 | -0.4 | -0.1 | -0.1 |
| OPM % | -129400% | % | -64.7% | -127.5% | -277.8% | -233.3% | -588.9% | -838.8% | -137.3% | -120.8% |
| Other Income | 0.0 | 0.0 | 0.1 | 4.4 | 0.0 | 0.0 | 0.1 | 0.7 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 0.1 | 3.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 2.5 | 2.5 | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | -2.6 | -2.6 | -2.5 | -13.9 | -0.1 | -0.1 | -0.3 | 0.2 | -0.1 | -0.1 |
| Tax % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 0% | -0% | -0% |
| Net Profit | -2.6 | -2.6 | -2.5 | -13.9 | -0.1 | -0.1 | -0.3 | 0.2 | -0.1 | -0.1 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 27% |
| 3 Years: | 11% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 25% |
| TTM: | 88% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 4% |
| 3 Years: | 9% |
| 1 Year: | -59% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 27% |
| 3 Years: | 11% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 14% |
| 3 Years: | 25% |
| TTM: | 88% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 4% |
| 3 Years: | 9% |
| 1 Year: | -59% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|